Osteoarthritis

MRI-based patient-specific nomogram for diagnostic risk stratification of patients with early knee OA

Rheumatology (Oxford)Published Diagnostic accuracy study

Authors' conclusion

A smaller volume of IPFP, T1ρ value >33 and T2 mapping >35.04 were significantly associated with OA.

Study context

Population
Patients with cartilage diagnosed as early-stage knee OA or normal, evaluated by MRI including T1rho and T2 mapping79 (39.7%) early OA
Participants
199 patients
Comparison
Training vs Validation
  • Trainingn = 115
  • Validationn = 84
Outcome
Discrimination of the OA-anatomical signature-nomogram (OA-ASN) for early-stage OA (C-index)
Methodological detailstraining and validation cohorts, bootstrap validation, multivariable analysis
  • Training and validation cohorts
  • Bootstrap validation
  • Multivariable analysis

Performance

As reported in the abstract

OA-ASN discrimination (C-index)
Test or modelValueBootstrap validation concordance index (C-index)
TrainingC-index 0.975 (95% CI 0.951–0.999)0.96
ValidationC-index 0.904 (95% CI 0.840–0.959)

Value

TrainingC-index 0.975 (95% CI 0.951–0.999)
ValidationC-index 0.904 (95% CI 0.840–0.959)

Bootstrap validation concordance index (C-index)

Training0.96
Validation— not stated in the abstract

Further findings

Independent predictors of early-stage OA (multivariable analysis)

Infrapatellar fat pad (IPFP), T1 rho and T2 mapping independently associated with early-stage OA

Calibration

Favourable consistency between nomogram prediction and actual observations in both training and validation cohorts

Clinical utility (decision curve analysis (DCA) and clinical impact curve (CIC))

Nomogram clinically useful

Original publication

MRI-based patient-specific nomogram for diagnostic risk stratification of patients with early knee OA. Rheumatology (Oxford). Published 6 June 2025. doi:10.1093/rheumatology/keaf319

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.